U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07488988) titled 'SCARFREE-001: Verteporfin for Scar Prevention' on March 13.
Brief Summary: The purpose of this clinical trial is to investigate whether the drug verteporfin can reduce the formation of scars in adult patients undergoing a tummy tuck procedure (abdominoplasty).
The main questions the study aims to answer are:
* Whether treatment with verteporfin can reduce scar formation in surgical wounds that are closed with sutures, compared with placebo (saline). This will be assessed based on how the scars look after 3 months using a standardized scar assessment questionnaire (Patient and Observer Scar Assessment Scale).
* Whether treatment ...